申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US03965111A1
公开(公告)日:1976-06-22
Triazolothienodiazepine compounds of the formula; ##SPC1## Wherein X is a member selected from the group consisting of a hydrogen atom, a methyl group, a methoxy group and a trifluoromethyl group; each of R.sup.1 and R.sup.2 is a member selected from the group consisting of a hydrogen atom and an alkyl group having 1 to 4 carbon atoms, or R.sup.1 and R.sup.2 together can form a tetramethylene group, i.e.--(CH.sub.2).sub.4 --; R is a member selected from the group consisting of a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, --CONHR.sup.3 (R.sup.3 being an alkyl group having 1 to 4 carbon atoms) and -alk-N(R.sup. 4)(R.sup.5) (each of R.sup.4 and R.sup.5 being a member selected from the group consisting of a hydrogen atom and an alkyl group having 1 to 4 carbon atoms, or R.sup.4 and R.sup.5 and N can form a heterocyclic ring; and alk being an alkylene group having 2 to 4 carbon atoms); and Z is a member selected from the group consisting of an oxygen atom and a sulphur atom; and the pharmaceutically acceptable acid addition salts thereof are disclosed. These compounds are useful as minor tranquillizers (anti-anxiety drugs), sleep inducers, and anti-epileptics.
三唑噻二氮杂环庚烯酮类化合物的结构式如下:##SPC1## 其中X为选自氢原子、甲基基团、甲氧基基团和三氟甲基基团的成员;R.sup.1和R.sup.2中的每一个为选自氢原子和碳原子数为1至4的烷基基团的成员,或者R.sup.1和R.sup.2一起可以形成四亚甲基基团,即--(CH.sub.2).sub.4--; R为选自氢原子、碳原子数为1至4的烷基基团、--CONHR.sup.3 (R.sup.3为碳原子数为1至4的烷基基团)和-烷基-N(R.sup.4)(R.sup.5) (R.sup.4和R.sup.5中的每一个为选自氢原子和碳原子数为1至4的烷基基团,或者R.sup.4和R.sup.5和N可以形成杂环环;烷基为碳原子数为2至4的烷基基团);Z为选自氧原子和硫原子的成员;以及其药用酸盐。这些化合物可用作轻度镇静剂(抗焦虑药物)、催眠剂和抗癫痫药物。